Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 32,676 Shares of Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 32,676 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $45.00, for a total value of $1,470,420.00. Following the transaction, the chief executive officer directly owned 388,044 shares of the company’s stock, valued at $17,461,980. This trade represents a 7.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Friday, August 14th, John C.M. Farquhar sold 15,560 shares of Heartflow stock. The stock was sold at an average price of $39.06, for a total value of $607,773.60.
• On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.31, for a total value of $638,730.22.
• On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total transaction of $626,095.50.
• On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00.
• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.

Heartflow Trading Up 2.8%

Shares of Heartflow stock traded up $1.27 during trading on Thursday, hitting $46.80. 1,989,666 shares of the stock were exchanged, compared to its average volume of 1,522,363. The company has a fifty day moving average price of $30.00 and a 200-day moving average price of $28.05. The stock has a market capitalization of $4.07 billion and a price-to-earnings ratio of -25.57. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $47.95.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. The business had revenue of $64.08 million during the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The company’s quarterly revenue was up 47.7% compared to the same quarter last year. Equities research analysts forecast that Heartflow, Inc. will post -0.82 EPS for the current fiscal year.

Institutional Investors Weigh In On Heartflow

A number of institutional investors have recently modified their holdings of HTFL. Alyeska Investment Group L.P. grew its stake in shares of Heartflow by 55.6% in the second quarter. Alyeska Investment Group L.P. now owns 350,000 shares of the company’s stock valued at $10,269,000 after acquiring an additional 125,000 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Heartflow by 3.6% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,465,650 shares of the company’s stock worth $43,002,000 after purchasing an additional 50,822 shares in the last quarter. XXEC Inc. bought a new stake in Heartflow in the 2nd quarter valued at about $18,364,000. Corient Private Wealth LP acquired a new position in shares of Heartflow during the 2nd quarter worth approximately $1,457,000. Finally, Bamco Inc. NY acquired a new position in shares of Heartflow during the 2nd quarter worth approximately $94,625,000.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Weiss Ratings raised Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 7th. Wells Fargo & Company raised their price target on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Stifel Nicolaus lifted their price objective on shares of Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research report on Friday, August 14th. William Blair assumed coverage on shares of Heartflow in a research report on Monday, May 4th. They issued an “outperform” rating on the stock. Finally, Canaccord Genuity Group raised their target price on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $43.43.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.